Multiple Sclerosis Clinical Trial
Study of Diroximel Fumarate in the Real-World Setting
The primary objective of the study is to characterize the persistence to therapy in participants with relapsing forms of multiple sclerosis (RMS) treated with diroximel fumarate (DRF) in routine clinical practice. The secondary objectives of the study are to assess short-term persistence to treatment; to assess long-term persistence on treatment; to assess the effect of DRF on relapses; to assess the impact of DRF on cognition; to assess the impact of DRF on participant reported outcomes (PROs) and to explore the real-world safety profile of DRF (ie, gastrointestinal [GI] tolerability, lymphocyte dynamics, adverse events [AEs] leading to discontinuation, and serious adverse events [SAEs]).
Key Inclusion Criteria:
Have a diagnosis of MS and satisfy the approved therapeutic indication for DRF per the USPI.
DRF prescribed and planned to be initiated within 60 days after enrollment.
Key Exclusion Criteria:
History of gastric bypass or required use of feeding tubes.
Have received prior treatment with DRF.
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 18 Locations for this study
West Hollywood California, 90048, United States
Washington District of Columbia, 20007, United States
Louisville Kentucky, 40207, United States
Boston Massachusetts, 02215, United States
Farmington Michigan, 48071, United States
Owosso Michigan, 48867, United States
Kansas City Missouri, 64111, United States
Freehold New Jersey, 07728, United States
Livingston New Jersey, 07039, United States
Neptune New Jersey, 07753, United States
Buffalo New York, 14202, United States
Greensboro North Carolina, 27405, United States
Portland Oregon, 97225, United States
Danville Pennsylvania, 17822, United States
Knoxville Tennessee, 37922, United States
Houston Texas, 77030, United States
Newport News Virginia, 23601, United States
Spokane Washington, 99204, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.